In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered
Open Access
- 2 February 2022
- journal article
- research article
- Published by Springer Nature in Drugs in R&D
- Vol. 22 (1) , 95-104
Abstract
Background and objective Swallowing difficulties (i.e., dysphagia) occur in up to 40% of the adult general population, particularly among the elderly prescribed solid oral dosage forms. Pimavanserin is approved for the treatment of hallucinations and delusions in patients with Parkinson’s disease psychosis (PDP) as a 34-mg capsule formulation. Patients with PDP may be at-risk for dysphagia that could affect administration of intact pimavanserin capsules. The stability of oral pimavanserin was evaluated in different liquid/soft food vehicles. Methods The stability of pimavanserin intended for oral administration was assessed by sprinkling the contents of 1 pimavanserin 34-mg capsule into water (40 mL), applesauce (40 g), vanilla Ensure (60 mL), or non-pulp orange juice (60 mL). Results The stability study demonstrated >95% recovery within 24 hours after contents of a 34-mg pimavanserin capsule were dispersed in applesauce, vanilla Ensure®, orange juice, or water. Assay values at 24 h for individual capsules were within 5% of time zero, and no significant change in the impurity profile was observed in any vehicle. Pimavanserin degradation products recovered from various food vehicles for individual and total degradation products were < 0.5% at all time points. In addition, the impurity profile of compatibility samples matched that obtained for a control sample. Conclusion These results support the ability of pimavanserin to be given orally by emptying the capsule contents into soft foods or liquids in accordance with the product label.Keywords
Funding Information
- ACADIA Pharmaceuticals
This publication has 19 references indexed in Scilit:
- Oral drug therapy in elderly with dysphagia: between a rock and a hard place!Clinical Interventions in Aging, 2017
- A Systematic Review of the Prevalence of Oropharyngeal Dysphagia in Stroke, Parkinson’s Disease, Alzheimer’s Disease, Head Injury, and PneumoniaDysphagia, 2016
- Pill Properties that Cause Dysphagia and Treatment FailureCurrent Therapeutic Research, 2015
- Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmaciesInternational Journal of Clinical Pharmacy, 2013
- Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage formsEuropean Journal of Clinical Pharmacology, 2012
- Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapyInternational Journal of Pharmaceutics, 2012
- Prevalence of oropharyngeal dysphagia in Parkinson’s disease: A meta-analysisParkinsonism & Related Disorders, 2012
- Medication administration through enteral feeding tubesAmerican Journal of Health-System Pharmacy, 2008
- Pill Swallowing by Adults With DysphagiaJAMA Otolaryngology–Head & Neck Surgery, 2005
- "Avoid the crush": hazards of medication administration in patients with dysphagia or a feeding tubeCanadian Medical Association Journal, 2005